QX
Quang X Pham sold $93K of CVKD stock
Quang X Pham, Chairman, CEO and Interim CFO, 10% of Cadrenal Therapeutics, Inc. (CVKD), sold 22,385 shares of CVKD stock worth $93K, per an SEC Form 4 filed Jun 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 8, 2026, 3 days before it was made public.
CVKD has moved -59.6% since the trade date, from $4.21 to $1.70 (Nov 20, 2026 close).
- Traded
- Jun 8, 2026
- Disclosed
- Jun 11, 2026
- Filing delay
- 3 days
- Price since
- -59.6%
- Role
- Chairman, CEO and Interim CFO, 10%
- Source
- SEC Form 4